Citation Impact
Citing Papers
Circulating Breast Tumor Cells Exhibit Dynamic Changes in Epithelial and Mesenchymal Composition
2013 StandoutScience
A target selection of somatic hypermutations is regulated similarly between T and B cells upon activation-induced cytidine deaminase expression
2005 StandoutNobel
An Ets2 -Driven Transcriptional Program in Tumor-Associated Macrophages Promotes Tumor Metastasis
2010
Integrin β 1 -focal adhesion kinase signaling directs the proliferation of metastatic cancer cells disseminated in the lungs
2009
Metastasis: from dissemination to organ-specific colonization
2009 Standout
Prognostic and Predictive Value of Tumor-Infiltrating Lymphocytes in a Phase III Randomized Adjuvant Breast Cancer Trial in Node-Positive Breast Cancer Comparing the Addition of Docetaxel to Doxorubicin With Doxorubicin-Based Chemotherapy: BIG 02-98
2013
Hypoxia-inducible factors and RAB22A mediate formation of microvesicles that stimulate breast cancer invasion and metastasis
2014 StandoutNobel
The measurement and therapeutic implications of circulating tumour cells in breast cancer
2005
ERalpha-status of disseminated tumour cells in bone marrow of primary breast cancer patients
2008
Computational design of soluble and functional membrane protein analogues
2024 StandoutNatureNobel
Hallmarks of Cancer: The Next Generation
2011 Standout
TGF-β inhibition enhances chemotherapy action against triple-negative breast cancer
2013
The relationship between prognostic and predictive factors in the management of breast cancer
1998
Endogenous human microRNAs that suppress breast cancer metastasis
2008 StandoutNature
Dissecting the metastatic cascade
2004
Gene Pathways Associated With Prognosis and Chemotherapy Sensitivity in Molecular Subtypes of Breast Cancer
2010
Human cancers express mutator phenotypes: origin, consequences and targeting
2011
K-ras Mutations and Benefit from Cetuximab in Advanced Colorectal Cancer
2008 Standout
Using tumour phylogenetics to identify the roots of metastasis in humans
2015
Genes that mediate breast cancer metastasis to the brain
2009 StandoutNature
High-resolution array comparative genomic hybridization of single micrometastatic tumor cells
2008
Epithelial-Mesenchymal Transitions in Development and Disease
2009 Standout
The cancer glycocalyx mechanically primes integrin-mediated growth and survival
2014 StandoutNatureNobel
Strong Time Dependence of the 76-Gene Prognostic Signature for Node-Negative Breast Cancer Patients in the TRANSBIG Multicenter Independent Validation Series
2007
Cancer Metastasis: Building a Framework
2006 Standout
Gene expression profiling spares early breast cancer patients from adjuvant therapy: derived and validated in two population-based cohorts
2005
Tumor heterogeneity: Causes and consequences
2009
Blockade of extracellular NM23 or its endothelial target slows breast cancer growth and metastasis
2015
Distant metastasis occurs late during the genetic evolution of pancreatic cancer
2010 StandoutNature
Tumor Metastasis: Molecular Insights and Evolving Paradigms
2011 Standout
Mechanisms of disseminated cancer cell dormancy: an awakening field
2014
Isolation of rare circulating tumour cells in cancer patients by microchip technology
2007 StandoutNature
Genetic determinants of cancer metastasis
2007
Models, mechanisms and clinical evidence for cancer dormancy
2007
Macrophage Diversity Enhances Tumor Progression and Metastasis
2010 Standout
Induction of EMT by Twist Proteins as a Collateral Effect of Tumor-Promoting Inactivation of Premature Senescence
2008
Significance, detection and markers of disseminated breast cancer cells
2006
Tumor metastasis: moving new biological insights into the clinic
2013
Latent Bone Metastasis in Breast Cancer Tied to Src-Dependent Survival Signals
2009
The Systemic Progression of Human Cancer: A Focus on the Individual Disseminated Cancer Cell—The Unit of Selection
2003
A concept for the standardized detection of disseminated tumor cells in bone marrow from patients with primary breast cancer and its clinical implementation
2006
WNT/TCF Signaling through LEF1 and HOXB9 Mediates Lung Adenocarcinoma Metastasis
2009
Hypoxia-inducible factor–dependent breast cancer–mesenchymal stem cell bidirectional signaling promotes metastasis
2012 StandoutNobel
Ubiquitin-dependent regulation of COPII coat size and function
2012 StandoutNatureNobel
Wnt/β-Catenin Signaling and Disease
2012 Standout
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
2016 Standout
The semaphorins: versatile regulators of tumour progression and tumour angiogenesis
2008
Immunity, Inflammation, and Cancer
2010 Standout
Evaluation of Factors Related to Late Recurrence - Later than 10 Years after the Initial Treatment - in Primary Breast Cancer
2013 Standout
Parallel progression of primary tumours and metastases
2009
Current and emerging concepts in tumour metastasis
2010
Distinct organ-specific metastatic potential of individual breast cancer cells and primary tumors
2005
EMT: 2016
2016 Standout
Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies
2011 Standout
EGFR in colorectal cancer: more than a simple receptor
2006
A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast Cancer
2004 Standout
GOBO: Gene Expression-Based Outcome for Breast Cancer Online
2011
Molecular Basis of Metastasis
2008
Microenvironmental regulation of metastasis
2008 Standout
Sipa1 is a candidate for underlying the metastasis efficiency modifier locus Mtes1
2005
Clonal evolution in cancer
2012 StandoutNature
Genomic analysis of single cytokeratin-positive cells from bone marrow reveals early mutational events in breast cancer
2005
Systemic Spread Is an Early Step in Breast Cancer
2008
Detection, clinical relevance and specific biological properties of disseminating tumour cells
2008
Macrophage biology in development, homeostasis and disease
2013 StandoutNature
Metastatic colonization by circulating tumour cells
2016 StandoutNature
Genes that mediate breast cancer metastasis to lung
2005 StandoutNature
Molecular mechanisms and clinical applications of angiogenesis
2011 StandoutNature
Tumour evolution inferred by single-cell sequencing
2011 StandoutNature
Heterogeneity within and between primary colorectal carcinomas and matched metastases as revealed by analysis of Ki-ras and p53 mutations
2004
Wnt/β-Catenin Signaling, Disease, and Emerging Therapeutic Modalities
2017 Standout
Breast cancer metastasis: markers and models
2005 Standout
Genomic Profiling of Viable and Proliferative Micrometastatic Cells from Early-Stage Breast Cancer Patients
2004
Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications
2001 Standout
Repeated observation of breast tumor subtypes in independent gene expression data sets
2003 Standout
A Perspective on Cancer Cell Metastasis
2011 StandoutScience
Cancer Immunoediting: Integrating Immunity’s Roles in Cancer Suppression and Promotion
2011 StandoutScience
A rare-cell detector for cancer
2004
Hypoxia-inducible factor 1-dependent expression of adenosine receptor 2B promotes breast cancer stem cell enrichment
2018 StandoutNobel
Immune targeting in breast cancer.
2015
Time independence of the prognostic impact of tumor cell detection in the bone marrow of primary breast cancer patients.
2001
Chemotherapy induces enrichment of CD47 + /CD73 + /PDL1 + immune evasive triple-negative breast cancer cells
2018 StandoutNobel
Prognostic and predictive value of PDL1 expression in breast cancer
2014
Metabolic reprogramming and cancer progression
2020 StandoutScience
Targeting claudins in cancer: diagnosis, prognosis and therapy.
2021
Histone demethylase JMJD2C is a coactivator for hypoxia-inducible factor 1 that is required for breast cancer progression
2012 StandoutNobel
Epithelial Plasticity: A Common Theme in Embryonic and Cancer Cells
2013 StandoutScience
HIF-1 regulates CD47 expression in breast cancer cells to promote evasion of phagocytosis and maintenance of cancer stem cells
2015 StandoutNobel
Chemotherapy triggers HIF-1–dependent glutathione synthesis and copper chelation that induces the breast cancer stem cell phenotype
2015 StandoutNobel
Hypoxia-inducible factor-dependent signaling between triple-negative breast cancer cells and mesenchymal stem cells promotes macrophage recruitment
2014 StandoutNobel
Circulating Tumor Cells and Bone Marrow Micrometastasis
2008
Different Gene Expression Patterns in Invasive Lobular and Ductal Carcinomas of the Breast
2004
Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer
2018 Standout
“Inverse Drug Discovery” Strategy To Identify Proteins That Are Targeted by Latent Electrophiles As Exemplified by Aryl Fluorosulfates
2017 StandoutNobel
Works of A. Ahr being referenced
Claudin-1 is linked to presence of implants and micropapillary pattern in serous borderline epithelial tumours of the ovary
2018
From latent disseminated cells to overt metastasis: Genetic analysis of systemic breast cancer progression
2003
Poor Outcome in Estrogen Receptor–Positive Breast Cancers Predicted by Loss of Plexin B1
2007
Data driven derivation of cutoffs from a pool of 3,030 Affymetrix arrays to stratify distinct clinical types of breast cancer
2009
Der Stellenwert der immunhistochemischen Bestimmung von Rezeptoren, Gewebsproteasen, Tumorsuppressorproteinen und Proliferationsmarkern als Prognoseindikatoren beim primären Mammakarzinom
1996
T-cell metagene predicts a favorable prognosis in estrogen receptor-negative and HER2-positive breast cancers
2009
P53 protein in 204 patients with primary breast carcinoma ? immunohistochemical detection and clinical value as a prognostic factor
1995
Cross-reactive staining of normal bone-marrow cells by monoclonal antibody 2E11
1999
Anti‐epidermal growth factor receptor‐antibody therapy for treatment of breast cancer
2002
A clinically relevant gene signature in triple negative and basal-like breast cancer
2011
Melanoma antigen family A identified by the bimodality index defines a subset of triple negative breast cancers as candidates for immune response augmentation
2011
Gene expression of topoisomerase II alpha (TOP2A) by microarray analysis is highly prognostic in estrogen receptor (ER) positive breast cancer
2008
Molecular classification of breast cancer patients by gene expression profiling*
2001
Prognostic value of cathepsin D in breast cancer: comparison of immunohistochemical and immunoradiometric detection methods.
1996
T cell marker metagene predicts a favourable prognosis in estrogen receptor negative and Her2 positive breast cancers.
2009